2012 Advisory Board

Andy has worked in AZ for 22 years (through ICI, Zeneca and then AstraZeneca) joining originally as a Chemical Engineer and have worked across all parts of the supply chain. In my early career I held a variety of Engineering and Production Management roles which included working in France More recent roles have including Global Supply Chain Manager, Engineering Manager for an API site undergoing major expansion, establishing a new logistics department on one of AZ's largest manufacturing sites and then subsequently leading it plus the Packaging Manufacturing during a major Lean transformation. Present role is the Business Lead for the roll-out of SAP APO across the business. 

Key supply chain project you are currently working on:
Global S & OP, Segmentation and improved planning and synchronisation along the supply chain and improving the professional capabilities of our Planning community

What is your major investment area within the supply chain?
EERP consolidation, roll-out of SAP SCM

What you foresee being your supply chain’s key challenge for the next 12 months, and how are you planning to overcome this?
Improved inventory management and better customer service and looking to significantly improve our end to end supply chain planning to drive improvements in these two areas. Also improved risk management and forecasting in our supply chains.

What benefits do plan to take home from LogiPharma?
Learn from best practises in other organisations and take the opportunity to build a broader network across the Pharma Industry

Philippe Francois is currently the Supply Chain vice president for Baxter healthcare for the Europe Middle East and Africa region He holds a master degree in engineering and an MBA and started his career in the automotive industry in France where he acquired a solid experience in Just in time techniques. He joined the healthcare industry where he has been working for the last 15 years and acquire an international experience in Europe and Asia where he had various managerial positions in the supply chain field for American and European multinationals. He is a certified black belt and has been using extensively business process improvement methodologies to shape product supply chain and drive business value for healthcare professionals. He is looking forward to share and exchange experience and ideas during the Logipharm conferences to position the supply chain as a strategic function within the pharma industry.

 

What you foresee being your supply chain’s key challenge for the next 12 months, and how are you planning to overcome this?
In the current economical context, all European healthcare systems are facing a tremendous pressure to control and reduce their cost. Customer expectations have changed. Supplying the right product at the right price is not good enough, people are looking for solutions which have to include additional services allowing them to be more efficient and reduce their costs. In that context the integration of the supply chain between supplier and customer is getting critical. The Pharma industry has to provide new services, based on new technologies to set up more agile supply channels, more integrated solutions. The collaboration between suppliers is becoming more critical to control our cost and focus on the value of the service. Standard labelling, standard tracking tools, shared distribution platform, shared transportation network are critical success factors.

What benefits do plan to take home from LogiPharma?
A forum like Logipharma is allowing supply chain professional form the pharmaceutical industry to exchange experience, expertise and best practices to build these new solutions which will allow us to provide the quality of care that patient are expected at an affordable cost.

Christoph is responsible for the global end-to-end distribution & supply chain and launch program for Pfizer’s Established Products Generics Segment. Before he was leading the strategic business support, the strategic planning and the strategic projects within logistics, distribution and supply for all Pfizer businesses in EMEA. An important part of his role was the EMEA-wide coordination of the conception, planning and implementation of innovative distribution models and network concepts, such as new distribution models and patient access approaches for emerging markets or distribution channel strategies such as the European Pfizer Direct-to-Pharmacy (DTP) initiative (i.e. UK). He joined Pfizer in 2005 as Senior Manager Logistics Planning for the European Market Logistics. Before joining Pfizer Christoph supported international chemical, pharmaceutical and biotechnology companies as part of the consulting firm A.T. Kearney. Key focus areas have been logistics/supply chain, distribution channel & commercial trade strategies, technical operations and post merger integration. Christoph holds a diploma in chemistry and a PhD in business administration (topic: strategies within the pharmaceutical industry).

Richard’s career has focused on global supply chain management for over 28 years, encompassing Life Sciences, Chemicals and Consumer Goods industries. A qualified Chemical Engineer, his early career was spent with the ICI Group of Companies where he fulfilled a wide range of roles including plant management, process engineering, operations excellence and strategic sourcing. In 1996, he joined the PricewaterhouseCoopers business consulting team, where he focused primarily on business restructuring, post merger integration and the design of operating models for global product supply. Richard recently joined the Lodestone Management Consulting team as Partner with responsibility for further extending their global supply chain business consulting capabilities.

After his degree in Business Administration with a major in Marketing at the Università Commerciale Luigi Bocconi of Milan in 1990, Paolo Rosanna started his career in international Freight Forwarding in the UK, USA and Italy with MSAS Cargo International. Paolo has developed his expertise both in operations and business development, focusing on Life Sciences & Healthcare, following the company in its re-organizations and integrations with Exel in 2003 and with DHL in 2006. At the beginning of 2007 Paolo moved from DHL’s Global Forwarding Division to DHL Supply Chain, the contract logistics arm of DHL, when he was appointed Business Development Director for Italy. After two years in the roles of Head of Life Sciences & Healthcare Development Mainland Europe and Vice President Business Development Western Europe, Paolo has been appointed from January 2012 in leading the agenda of Business Development of Life Sciences & Healthcare Sector in EMEA.

Paolo was born in Stresa, Italy, in 1965 and is married with two sons. In his spare time he is passionate about football.

Stephen Gotthardt has been with Boehringer Ingelheim since 1999. In his current position, he is Corporate Vice President Supply Chain & Key Account Management and is based in Germany. Since 2000, Stephan has been a key member and chairperson of Boehringer Ingelheim’s worldwide supply chain organization and of its Global Supply Chain Conferences.

For the best part of ten years James (Jim) Hood spent his time creating Global Supply Chain Management functions within the Generics Pharmaceutical industry.
Since April 2011, Jim’s role has been Global Business Programme Owner for the Global ERP roll-out, to over 30 ComOps Affiliates and 20 Manufacturing Sites worldwide. Defining core business processes, and overseeing the implementation of a Business Transformation Initiative, aimed at creating a harmonized network, required to synchronize data and transparency of management information across the whole business.

Key supply chain project you are currently working on:
Harmonising Demand & Supply Business Processes and Performance Management Reports & KPIs, on a Standard SAP Technology Platform. This includes: MRP, RCCP and Global S & OP; Creating a truly integrated and synchronised end to end Supply Chain.

What is your major investment area within the supply chain?
SAP - EEC; Business Intelligence/Business Objects for Performance Management and Business Metrics,

What you foresee being your supply chain’s key challenge for the next 12 months, and how are you planning to overcome this?
Improved inventory management and better customer service and looking to significantly improve our end to end supply chain planning through more robust S&OP..

What benefits do you plan to take home from LogiPharma?
Understand how other companies are addressing the same kind of challenges within the Pharma Industry

John has joined Bayer Healthcare almost 4 years ago and in this function he is responsible for Global end to end supply chain for all 4 divisions. In this function he has strategic and tactical responsibilities for the world wide availability of product. In the last 3 years John lead the program to optimize inventories and increase its service levels and this resulted in a 600 million Cash improvement and an increased service level for all divisions.

John is a trained officer of the Dutch Marines (Platoon Commander) and studied business engineering in Eindhoven and holds an international executive MBA from IBO in Zeist.

 

Key supply chain project you are currently working on:
Lean supply chain (lead time reduction), Supplier integration and process standardization.

What is your major investment area within the supply chain?
One Global ERP tool and SCM knowledge improvement

What you foresee being your supply chain’s key challenge for the next 12 months, and how are you planning to overcome this?
Decomplexation of our supply chain (tools and processes)

What benefits do plan to take home from LogiPharma?
Creative SCM thoughts and possible SCM collaboration with a few industry colleagues for the near future